Leadership Change at the Society of Interventional Radiology
The Society of Interventional Radiology (SIR) recently announced the appointment of Eve Lee, MBA, CAE, as its new chief executive officer. Ms. Lee is set to officially step into her role on January 27, 2025. Her extensive experience in healthcare leadership positions her well to enhance the organization's mission.
Strengthening Advocacy and Education
As Ms. Lee takes on this pivotal role, she aims to further SIR's commitment to advocacy, education, and policy initiatives. Her mission will focus on reinforcing the practice of interventional radiology while ensuring that patients have access to minimally invasive, image-guided therapies. Her leadership is expected to significantly advance the SIR Foundation's goals, particularly in the areas of research and fundraising.
A Vision for the Future
"I am thrilled and honored to join SIR as it embarks on its 50th anniversary year," expressed Ms. Lee. She is eager to build upon SIR's strong foundation, emphasizing advocacy, education, and research, which are vital in expanding access to interventional radiology care globally.
Previous Experience and Achievements
Prior to her role at SIR, Ms. Lee served as the executive director of the American Orthotic and Prosthetic Association (AOPA). During her tenure at AOPA, she advocated for better patient access to care and nurtured evidence-based advocacy efforts. Furthermore, she fostered strategic partnerships that extended AOPA's global outreach, solidifying its position as a significant voice in healthcare policy.
Innovative Leadership in Healthcare
Before joining AOPA, Ms. Lee led the Society for Healthcare Epidemiology of America (SHEA) as its executive director. Under her guidance, SHEA established itself as a leader in infection prevention and public health policy, collaborating with significant organizations like the CDC and FDA to address urgent healthcare issues.
Educational Background and Qualifications
Ms. Lee's educational background enhances her qualifications for this pivotal role. She holds an MBA from the University of Maryland Global Campus, a certificate in higher education teaching from Harvard University, and an undergraduate degree in political science from Randolph-Macon College.
About the Society of Interventional Radiology
The Society of Interventional Radiology is a nonprofit, professional medical society dedicated to advancing the field of interventional radiology. Representing over 8,000 members, including practicing physicians, trainees, and clinical associates, SIR is committed to enhancing patient care through the potential of image-guided therapies. Its members operate in various professional settings, ensuring a comprehensive approach to patient treatment.
About the Society of Interventional Radiology Foundation
The SIR Foundation is dedicated to promoting research and education in interventional radiology, aiming to expand scientific knowledge and develop innovative therapies that improve patient care and quality of life. The foundation plays a pivotal role in advancing the overall mission of SIR.
Frequently Asked Questions
Who is Eve Lee?
Eve Lee is the newly appointed chief executive officer of the Society of Interventional Radiology, set to begin her role on January 27, 2025.
What are the main goals of Eve Lee as the new CEO?
Ms. Lee aims to strengthen SIR's advocacy, education, and research efforts to improve patient access to interventional radiology globally.
What previous positions did Eve Lee hold?
Before joining SIR, Ms. Lee served as the executive director of both the American Orthotic and Prosthetic Association and the Society for Healthcare Epidemiology of America.
What is the Society of Interventional Radiology?
SIR is a nonprofit medical society that represents over 8,000 interventional radiology professionals, focused on improving patient care through advanced interventional therapies.
What does the SIR Foundation do?
The SIR Foundation supports research and education in interventional radiology, aiming to enhance scientific knowledge and develop innovative patient care therapies.
